M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection
27 Apr, 2021 | 08:44h | UTCProphylaxis against covid-19: living systematic review and network meta-analysis – The BMJ